Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Bronchiectasis ...

A rare ABPA case presenting with pyopneumothorax underscores diagnostic challenges and the importance of timely treatment.

DANVILLE, Pa. – Geisinger researchers have discovered a link between chronic sinus disease and bronchiectasis, a chronic and progressive lung disease. The findings, published in the Journal of Allergy ...

Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as ...

Patients with bronchiectasis recovering from severe COVID-19 face higher risks of exacerbation and mortality compared to nonsevere cases. The study utilized data from Korea's National Health Insurance ...

Insmed plans to file a New Drug Application with the Food and Drug Administration in the fourth quarter of 2024. Treatment with brensocatib reduced the frequency of pulmonary exacerbations in patients ...

Please provide your email address to receive an email when new articles are posted on . Brensocatib given as 25 mg performed better than placebo when assessing rate of pulmonary exacerbations and lung ...

Please provide your email address to receive an email when new articles are posted on . For adults with bronchiectasis, $82,545 was the highest annual health care cost observed in a systematic review.

Researchers from the University of Ottawa and The Ottawa Hospital have found marijuana smokers have a higher rate of emphysema and airway diseases compared to cigarette smokers. The findings, ...